LifeStance Health Files 8-K on Shareholder Vote Matters

TL;DR

LifeStance Health had a shareholder vote on June 3rd. Details filed today.

AI Summary

LifeStance Health Group, Inc. filed an 8-K on June 4, 2024, reporting on matters submitted to a vote of its security holders on June 3, 2024. The filing details the company's principal executive offices located at 4800 N. Scottsdale Road, Suite 2500, Scottsdale, Arizona, 85251. The report was filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

Why It Matters

This filing indicates that LifeStance Health Group, Inc. held a vote of its security holders, which could pertain to significant corporate decisions or governance changes.

Risk Assessment

Risk Level: low — This is a routine filing reporting on a shareholder vote, with no immediate financial or operational risks indicated.

Key Players & Entities

• LifeStance Health Group, Inc. (company) — Registrant
• June 3, 2024 (date) — Date of earliest event reported
• June 4, 2024 (date) — Date of Report
• 4800 N. Scottsdale Road, Suite 2500, Scottsdale, Arizona, 85251 (location) — Principal Executive Offices

FAQ

Key Financial Figures

• $0.01 — ich registered Common Stock, par value $0.01 per share LFST The Nasdaq Stock Mar

Filing Documents

• d841823d8k.htm (8-K) — 36KB
• 0001193125-24-154291.txt ( ) — 155KB
• lfst-20240603.xsd (EX-101.SCH) — 3KB
• lfst-20240603_lab.xml (EX-101.LAB) — 18KB
• lfst-20240603_pre.xml (EX-101.PRE) — 11KB
• d841823d8k_htm.xml (XML) — 4KB

From the Filing

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 3, 2024 LifeStance Health Group, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-40478 86-1832801 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 4800 N. Scottsdale Road Suite 2500 Scottsdale , Arizona 85251 (Address of Principal Executive Offices) (Zip Code) Registrant's Telephone Number, Including Area Code: 425 279-8500 (Former Name or Former Address, if Changed Since Last Report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.01 per share LFST The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 ( 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 ( 240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item5.07 Submission of Matters to a Vote of Security Holders. On June 3, 2024, LifeStance Health Group, Inc. (the "Company") held its annual meeting of stockholders (the "Annual Meeting"). The following is a brief description of each proposal voted upon at the Annual Meeting and the final voting results for each such proposal. Proposal 1: Election of Directors The stockholders of the Company elected the director nominees listed below to serve on the Company's Board of Directors as members of Class III for a term of three years. The results of the vote were as follows: Name of Nominee For Withhold Broker Non-Votes Kenneth Burdick 296,275,655 39,857,449 15,918,580 Jeffrey Rhodes 291,334,953 44,319,757 16,396,974 William Miller 296,766,053 40,026,251 15,259,380 Proposal 2: Ratification of the Company's Independent Registered Public Accounting Firm The stockholders of the Company ratified the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the year ended December 31, 2024. The results of the vote were as follows: For Against Abstain 339,827,488 370,822 11,853,374 Proposal 3: Advisory Vote on Named Executive Officer Compensation The stockholders of the Company approved, on a non-binding advisory basis, the Company's named executive officer compensation. The results of the vote were as follows: For Against Withhold Broker Non-Votes 282,059,174 50,777,777 3,982,869 15,231,864 Proposal 4: Frequency of the Advisory Vote on Named Executive Officer Compensation The stockholders of the Company approved, on a non-binding advisory basis, that future non-binding advisory votes on the Company's named executive officer compensation be held every year. The results of the vote were as follows: 1 Year 2 Years 3 Years Broker Non-Votes 322,160,935 58,179 11,299,991 15,231,864 As a result of the foregoing vote, the Company's Board of Directors has determined that the Company will conduct a non-binding advisory vote on the Company's named executive officer compensation every year. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LIFESTANCE HEALTH GROUP, INC. Date: June 4, 2024 By: /s/ Ryan Pardo Name: Ryan Pardo Title: Chief Legal Officer and Secretary

View Full Filing

View this 8-K filing on SEC EDGAR